Learn about
Staphage Lysate.

In order to minimize recurrent outbreaks and avoid prolonged exposure to antibiotics, concurrent treatment with immunotherapies such as Staphage Lysate (SPL)® may be recommended.

Find out More
0
Years Treating Dogs

0
Countries

0,000+
Dogs treated

Does your Dog get Recurrent Staph
Skin Infections?

Find out about one of the most frequently seen conditions in veterinarian’s offices. It is also one of the most stubborn conditions to treat.

Info for Dog Owners

Common Questions.

Staphage Lysate (SPL)® stimulates cytokines that enhance the patient’s immune reactions against skin-associated bacteria (including staphylococcal strains) that cause or exacerbate Canine Pyoderma.

See more FAQ’s
Canine pyoderma is a staphylococcal bacterial infection of the skin that is commonly seen in dogs.
Staphage Lysate is the only staph product of its kind approved for canine use that can reduce the recurrences of infection and stimulate the immune system simultaneously.
SPL® is indicated for the use on dogs with recurrent pyoderma. SPL® is not a primary treatment to initially eliminate the infection. Rather it is a treatment that prevents recurrence. SPL® can be initiated at the same time the primary treatment (topical treatment or antibiotics) is started.
SPL® begins to work in about 10 -12 weeks, shortly after the time that a 4 to 6 week regimen of antibotics is discontinued.

Are you offering Staphage Lysate?

Find out how you can offer this effective solution to your clients.

Get Info